drugset / Trial / NCT00754949

Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

NCT00754949

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if AzaSite Plus is effective and safe for the treatment of blepharoconjunctivitis compared to AzaSite alone and Dexamethasone alone.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azithromycin Small molecule 1 % Topical
Comparator Dexamethasone Small molecule 0.1 % Topical